Haematological malignancies implications during the times of the COVID-19 pandemic

The COVID-19 pandemic has complicated current healthcare services for cancer patients. Patients with haematological malignancies specifically seem vulnerable to SARS-CoV-2 infection due to their immunosuppressed status. The COVID-19 pandemic influences every step of the assessment and treatment of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Papakonstantinou, Eleni, Dragoumani, Konstantina, Efthimiadou, Aspasia, Palaiogeorgou, Anastasia Marina, Pierouli, Katerina, Mitsis, Thanasis, Chrousos, George P., Bacopoulou, Flora, Vlachakis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581473/
https://www.ncbi.nlm.nih.gov/pubmed/34777590
http://dx.doi.org/10.3892/ol.2021.13117
Descripción
Sumario:The COVID-19 pandemic has complicated current healthcare services for cancer patients. Patients with haematological malignancies specifically seem vulnerable to SARS-CoV-2 infection due to their immunosuppressed status. The COVID-19 pandemic influences every step of the assessment and treatment of a haematological malignancy. Clinicians must adhere to strict policies to not spread the virus to their patients while they must also adjust their workflow for maximum productivity. These difficulties accentuate the ever-present need to improve the healthcare services for cancer patients. This improvement is needed not only to combat the problems that arose from the COVID-19 pandemic but also to establish a framework for the management of patients with haematological malignancies in potential future pandemics.

Ejemplares similares